Warning: include(/_includes/php/about-nav.html) [function.include]: failed to open stream: No such file or directory in /home2/dbiosysc/public_html/about/news.html on line 48
Warning: include() [function.include]: Failed opening '/_includes/php/about-nav.html' for inclusion (include_path='.:/usr/lib64/php:/usr/lib/php') in /home2/dbiosysc/public_html/about/news.html on line 48
In The News
To learn more about DBS latest developments read news below.
PRESS RELEASE FOR IMMEDIATE RELEASE
August 26, 2009
Diagnostic BioSystems launches Immunohistochemistry offering to the US Clinical Market
IVD labeling and ISO 9001:2000 pave the way for commercial entry in the US IVD market
Pleasanton, CA (BUSINESS WIRE) August 26, 2009 – Diagnostic Biosystems (DBS), a specialty immunohistochemistry (IHC) reagent company, announces the availability of products for clinical use in the US.
Founded in 1994 as a life science supplier of novel, high quality IHC products in over 45 countries, DBS introduces a complete selection of IVD labeled staining reagents suitable for manual and automated staining platforms. DBS offers IVD labeled concentrated and pre-diluted ready-to-use primary antibodies and immunostaining detection systems for rabbit and mouse antibodies: advanced biotin-free polymer systems as well as traditional streptavidin-biotin systems labeled with horseradish peroxidase or alkaline phosphatase.
Unique to the Diagnostic Biosystems offering are antibody cocktails and proprietary chromogens for multicolor staining, focused on improving sensitivity and defining morphology on one tissue section for potentially cancerous cells. Novel antibodies and multi-stain products include:
Founded in 1994 as a life science supplier of novel IHC products, DBS is currently selling its products in over 45 countries around the world and is recognized for high quality, robust IHC reagents. DBS introduces a complete selection of IVD labeled concentrated and pre-diluted ready-to-use primary antibodies, IVD labeled immunostaining detection systems employing biotin free poly HRP and Alkaline Phosphatase technology, as well as wide range of ancillary reagents. The DBS staining reagents are suitable for manual and can be utilized on various automated staining platforms.
Unique to the Diagnostic Biosystems offering are novel antibodies as well as multi-stain cocktails focused on improving sensitivity and differentiation between the cancerous and non cancerous cells, not possible with individual stains. Novel antibodies and multi-stain products include:
- PIN4
- DOG-1
- Napsin A
- OCT4
- PermaRed/AP-Auto
- PermaBlue/AP
- PermaGreen/AP
- Stable DAB/Plus
"Diagnostic Biosystems is focused on developing clinically relevant, IVD labeled products, for pathologists in the US. We are dedicated to providing the highest quality reagents for clinical labs. We understand high quality staining is the key to better diagnosis by Pathologists. We are committed to improving immunostaining one slide at a time, said Dr. Bipin Gupta, PhD, President & CEO."
For additional information on the product availability, contact customer care at 888-896-3350 or visit www.dbiosys.com. IVD products are available immediately.
About Diagnostic Biosystems Company:
Diagnostic Biosystems is a leading developer of high quality Immunohistochemistry reagents. Founded in 1994, the company is dedicated to high quality antibody production and development of novel multiplex staining reagents. Building on its strong global presence, Diagnostic Biosystems produces novel, clinically relevant tools for pathology market including: monoclonal and polyclonal antibodies, a wide range of detection systems and ancillary reagents for high quality immunostaining. Custom Monoclonal and Polyclonal Antibody Production Services include peptide synthesis, in vitro and in vivo antibody production, purification and conjugation.
Diagnostic BioSystems is an FDA registered medical device manufacturer, operating under FDA 21CFR Part 820 Quality System Regulations and certified under ISO 9001:2000 Quality Management System International standards, manufacturing CE marked medical devices, for use in the European market.
Contact: Martha Townsend at Diagnostic BioSystems, 888 896 3350; martha.townsend@dbiosys.com.